Exploring new roles for ADAR1 in cancer; generation of novel neoantigens, links with p53 and the effects of cancer treatment on ADAR1 activity
Badanie nowych ról białka ADAR1 w nowotworach; udział w tworzeniu neoantygenów, powiązanie z białkiem p53 oraz wpływ terapii przeciwnowotworowych na aktywność białka ADAR1 (editRNA)
Funding source:
National Science Centre (NCN), WEAVE-UNISONO
Project Duration:
01.06.2022-31.05.2025
Principal Investigator:
dr Małgorzata Kurkowiak
Funding amount:
1 588 978 PLN (~353 000 €)
Funding agreement / decision number:
UMO-2021/03/Y/NZ2/00055
Funding „Premia na Horyzont” for the project KATY

Funding source:
Ministry for Education and Science (MEiN), Premia na Horyzont
Project Duration:
01.01.2021-31.12.2024
Principal Investigator:
dr Javier Alfaro
Funding amount:
591 040 PLN
(~131 000 € )
Funding agreement / decision number:
507056/PnH2/2021
Project Duration:
01.01.2021-30.06.2025
Principal Investigator:
dr Javier Alfaro
Funding amount:
Total:
8 479 900 €;
ICCVS UG:
649 781,25 €
Funding agreement / decision number:
GA no. 101017453
Project Duration:
01.10.2022-30.09.2023
Principal Investigator:
dr Zuzanna Urban-Wójciuk
Funding amount:
47 520 PLN
(~10 560€)
Funding agreement / decision number:
DEC-2022/06/X/NZ3/00691
Impact of IFITM1 and IFITM3 genes on qualitative and quantiative changes in repertoir of peptides presented by MHC class I molecules in cellular model of cervical cancer
Wpływ genów IFITM1 oraz IFITM3 na zmiany jakościowe i ilościowe repertuaru peptydów prezentowanych przez cząsteczki MHC klasy I w modelu komórkowym raka szyjki macicy
Funding source:
National Science Centre (NCN), MINIATURA 5
Project Duration:
15.12.2021-14.12.2022
Principal Investigator:
dr Maria Gomez Herranz
Funding amount:
35 750 PLN
(~8 000 €)
Funding agreement / decision number:
DEC-2021/05/X/NZ1/01748
Project Duration:
02.12.2021-01.12.2022
Principal Investigator:
dr Jakub Faktor
Funding amount:
49 830 PLN
(~11 000 €)
Funding agreement / decision number:
DEC-2021/05/X/NZ1/00766
Project Duration:
03.11.2021-02.11.2022
Principal Investigator:
dr Małgorzata Lisowska
Funding amount:
49 711 PLN
(~11 000 €)
Funding agreement / decision number:
DEC-2021/05/X/NZ3/00602
Funding „Premia na Horyzont” for the project IMMUNE-GENEMEMO

Funding source:
Ministry for Education and Science (MEiN), Premia na Horyzont
Project Duration:
01.06.2021-30.05.2024
Principal Investigator:
dr Wojciech Siwek
Funding amount:
222 413 PLN
(~50 000 €)
Funding agreement / decision number:
516254/PnH2/2021
IMMUNE-GENEMEMO: Identification of transcriptional memory maintenance factors through a cell selection strategy
Identyfikacja czynników utrzymania pamięci transkrypcyjnej poprzez strategię selekcji komórek
Funding source:
European Commission, Horizon 2020, Marie Skłodowska-Curie Actions Individual Fellowships (MSCA IF)
Project Duration:
01.06.2021-30.05.2024
Principal Investigator:
dr Wojciech Siwek
Funding amount:
252 078,72 €
Funding agreement / decision number:
GA no. 101025900
Project Duration:
16.10.2020-15.12.2021
Principal Investigator:
dr Artur Piróg
Funding amount:
41 800 PLN
(~9 000 €)
Funding agreement / decision number:
DEC-2020/04/X/NZ6/00259
Project Duration:
01.12.2020-30.11.2023
Principal Investigator:
dr Umesh Kalathiya
Funding amount:
604 075 PLN
(~134 000 €)
Funding agreement / decision number:
UMO-2020/36/C/NZ2/00108
International Centre for Cancer Vaccine Science: Equipment Grant (cell sorting)

Funding source:
Foundation for Polish Science, European Development Fund, Operational Programme Smart Growth, 4.3. International Research Agenda Programme
Project Duration:
2019
Principal Investigator:
prof. dr. hab. Natalia Marek-Trzonkowska
Funding amount:
2 711 230 PLN
(~0,6m €)
Funding agreement / decision number:
MAB/2017/3-AS2
International Centre for Cancer Vaccine Science: Equipment Grant (mass spectrometry)

Funding source:
Foundation for Polish Science, European Development Fund, Operational Programme Smart Growth, 4.3. International Research Agenda Programme
Project Duration:
2019
Principal Investigator:
dr Irena Dapic
Funding amount:
4 716 361 PLN
(~1 m €)
Funding agreement / decision number:
MAB/2017/3-AS2
International Centre for Cancer Vaccine Science

Funding source:
Foundation for Polish Science, European Development Fund, Operational Programme Smart Growth, 4.3. International Research Agenda Programme
Project Duration:
1.10.2017-31.12.2023
Principal Investigator:
prof. Natalia Marek-Trzonkowska (since 2021)
prof. Ted Hupp (2017-2021)
Funding amount:
42 122 280 PLN
(~9.4 m €)
Funding agreement / decision number:
MAB/2017/3
